Austin R. Dosch - Concepedia

Author

Austin R. Dosch

University of Miami

Also Known As

A. Dosch, A. R. Dosch, A.R. Dosch, Austin Dosch, Austin R. Dosch, Austin Ronald Dosch, Dosch, Austin, Samara Singh

125

Publications

972

Citations

H-Index

Concepts

All Affiliations

University of Miami Sylvester Comprehensive Cancer Center Vanderbilt University University of California, Irvine Medical Center University of California, Irvine

About

Austin R. Dosch is an author at University of Miami specializing in medicine, surgery, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	293
2	Cell Biology	2	2	193
3	Gastroenterology	2	2	58
4	Health Sciences	1	1	15
5	Emergency Medicine	1	1	15

Austin R. Dosch

Publications

866

Citations

H-Index

Page 1

	Year	Citations
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer Jashodeep Datta, Xizi Dai, Anna Bianchi, Gastroenterology Lineage PlasticityPancreatic CancerOvercome Immunotherapy ResistanceMedicineStem Cells	2022	149
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD Tamara Isakova, Allison Barchi-Chung, Gwen Enfield, Clinical Journal of the American Society of Nephrology	2013	146
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna R. Jala, Molecular Cancer Therapeutics	2018	116
Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy Casey J. Allen, Danny Yakoub, Francisco Igor Macedo, Annals of Surgery	2018	53
Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer Austin R. Dosch, Samara P. Singh, Xizi Dai, Molecular Cancer Therapeutics	2021	52
Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer Austin R. Dosch, Xizi Dai, Michelle L. Reyzer, Molecular Cancer Research	2020	49
Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma Brent A. Willobee, Alexander A. Gaidarski, Austin R. Dosch, Molecular Cancer Therapeutics	2021	45
Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer Supriya Srinivasan, Tulasigeri M. Totiger, Chanjuan Shi, Cancer Research	2018	44
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Oncogene Distinct MechanismsCancer ImmunosurveillancePancreatic CancerMedicineImmunology	2022	44
Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways Kousik Kesh, Vanessa T. Garrido, Austin R. Dosch, Cell Death and Disease	2020	40

Page 1